GAME [Shanda Games] 424B4: (Original Filing)
[]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea Clarifies Details of Agreement with Boryung BEIJING, Sept. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company
[Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea Clarifies Details of Agreement with Boryung BEIJING, Sept. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
NCTY [The9] 6-K: (Original Filing)
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Selects Deloitte as its Independent Registered Public Accounting Firm Shanghai, China September 28, 2009. The9 Limited (NASDAQ: NCTY) (The9 or the Company), an online game operator and developer in China, today announced that the Audit Committee of its Board of Directors has engaged the services of Deloitte Touche]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac's H1N1 Vaccine Passes Experts Evaluation Organized by SFDA BEIJING, Aug. 31 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac's H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production license within this week. On] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
NCTY [The9] 6-K: THE9 LIMITED Jun Zhu Chairman and Chief Executive
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Selects Deloitte as its Independent Registered Public Accounting Firm Shanghai, China September 28, 2009. The9 Limited (NASDAQ: NCTY) (The9 or the Company), an online game operator and developer in China, today announced that the Audit Committee of its Board of Directors has engaged the services of Deloitte Touche]
SVA [SINOVAC BIOTECH] 6-K: Sinovac’s H1N1 Vaccine Passes Experts Evaluation Organized by
[Sinovac's H1N1 Vaccine Passes Experts Evaluation Organized by SFDA BEIJING, Aug. 31 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac's H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production license within this week. On] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
CHA [CHINA TELECOM] CORRESP: (Original Filing)
[September 28, 2009 Mr. Larry Spirgel, Assistant Director, Mail Stop 3720, Division of Corporation Finance, 100 F Street, N.E., Re: China Telecom Corporation Limited Annual Report on Form 20-F for the Fiscal Year ended December 31, 2008 (File No. 001-31517) Dear Mr. Spirgel: Staff SEC Company Form 20-F This is in response to the comment letter from the staff (the]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Wins Beijing Public Health Bureau's Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens BEIJING, Aug. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
